RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS
Abstract
This review about the application of radiotherapy in breast cancer patients after radical mastectomy. Emphasizes the need for a differentiated approach to radiation therapy, which should be based on the definition of clinical morphological factors that determine the risk of loco-regional recurrence of breast cancer.
About the Authors
K. A. Simonov
Tomsk Cancer Research Institute; National Research Tomsk Polytechnic University
Russian Federation
Russian Federation
Zh. A. Startseva
Tomsk Cancer Research Institute; National Research Tomsk Polytechnic University
Russian Federation
Russian Federation
E. M. Slonimskaya
Tomsk Cancer Research Institute; Siberian State Medical University, Tomsk
Russian Federation
Russian Federation
References
1. Martinez-Ramos D., Escrig J., Torrella A., Hoashi J.S., Alcalde M., Salvador J.L. Risk of recurrence of non-metastatic breast cancer in women under 40 years: a population registry cancer study in a European country // Breast J. 2012. Vol. 18. (2). Р. 118–123. doi: 10.1111/j.15244741.2011.01208.x.
2. Efimkina Yu.V., Gladilina I.A., Shabanov M.A. Comparative analysis of the long-term results of treatment of patients with breast cancer stages I–IIA according to the main prognostic factors // Opukholi zhenskoy reproduktivnoy sistemy. 2010. № 4. P. 6–9. [in Russian]
3. Matsunuma R., Oguchi M., Fujikane T., Matsuura M., Sakai T., Kimura K., Morizono H., Iijima K., Izumori A., Miyagi Y., Nishimura S., Makita M., Gomi N., Horii R., Akiyama F., Iwase T. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (3). Р. 845–852. doi: 10.1016/j.ijrobp.2011.08.029.
4. Zhogina Zh.A., Musabaeva L.I., Slonimskaya E.M. Indications for the choice of adjuvant radiotherapy extent for patients breast cancer after radical mastectomy // Sibirskiy onkologicheskiy zhurnal. 2005. № 3. P. 3–10. [in Russian]
5. Miles R.C., Gullerud R.E., Lohse C.M., Jakub J.W., Degnim A.C., Boughey J.C. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age // Ann. Surg. Oncol. 2012. Vol. 19 (4). Р. 1153–1159. doi: 10.1245/s10434-011-2084-6.
6. Simonov K.A., Startseva Zh.A., Slonimskaya E.M. Long-term outcomes in breast cancer patients after complex treatment with adjuvant radiation therapy // Sibirskiy onkologicheskiy zhurnal. 2013. Vol. 56 (2). P. 30–35. [in Russian]
7. Moo T. A., McMillan R., Lее M., Stempel M., Patil S., Ho A., ElTamer M. Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph Nodes // Ann. Surg. Oncol. 2013. Vol. 20 (10). Р. 3169–3174. doi: 10.1245/s10434-013-3117-0.
8. Simonov K.A., Startseva Zh.A., Slonimskaya E.M. Role of postoperative radiotherapy in the treatment of breast cancer patients // Bjulleten’ Sibirskogo otdelenija Rossijskoj akademii medicinskih nauk. 2012. Vol. 32 (6). P. 34–40. [in Russian]
9. Munshi A., Prabhu A., Kunkler I. Post mastectomy radiotherapy in one to three lymph node positive breast cancer // Acta Oncol. 2012. Vol. 51 (4). Р. 547–550. doi: 10.3109/0284186X.2011.633929.
10. Startseva Zh.A., Velikaya V.V., Simonov K.A., Musabaeva L.I. Postoperative radiation therapy as a method of prevention of local recurrence of breast cancer // Radiatsiya i risk. 2013. T. 22. № 3. P. 72–79. [in Russian]
11. Nagao Т., Kinoshita Т., Tamura N., Hojo T., Morota M., Kagami Y. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2013. Vol. 18 (1). Р. 54–61. doi: 10.1007/s10147-0110343-y.
12. Startseva Zh.A., Simonov K.A., Slonimskaya E.M. Differentiated approach to adjuvant radiotherapy in patients with operable breast cancer // Radiatsiya i risk. 2014. T. 23. № 2. P. 102–111. [in Russian]
13. Nixon A., Neuberg D., Hayes D., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. Vol. 12. Р. 888–894.
14. Shchepotin I.B., Zotov A.S., Zaychuk V.V. Risk factors for local recurrence of invasive breast cancer // Onkologiya. 2010. T. 4. № 12. P. 347–350. [in Russian]
15. Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. Vol. 82 (3). P. 247−253.
16. Abi-Raad R., Boutrus R., Wang R., Niemierko A., Macdonald S., Smith B., Taghian A.G. Patterns and risk factors of locoregional recurrence in T1–T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81 (3). Р. 151–157. doi: 10.1016/j.ijrobp.2011.01.015.
17. Panoff J.E., Hurley J., Takita C., Reis I.M., Zhao W., Sujoy V., Gomez C.R., Jorda M., Koniaris L., Wright J.L. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation // Breast Cancer Res. Treat. 2011. Vol. 128 (3). Р. 899–906. doi: 10.1007/s10549-011-1495-1.
18. Altinyollar H., Berberoрlu U., Irkin F. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer // J. Surg. Oncol. 2007. Vol. 95 (7). Р. 567–571.
19. Patani N., Carpenter R. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer // Breast J. 2010. Vol. 16 (3). Р. 222–232. doi: 10.1111/j.1524-4741.2010.00917.x.
20. Anderson P., Freedman G., Nicolaou N., Sharma N., Li T., Topham N., Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 74 (1). P. 81–85. doi: 10.1016/j.ijrobp.2008.06.1940.
21. Paul S., Srivastava K., Chaudhuri T., Rathor S. Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate? // Clin. Cancer Investig J. 2013. Vol. 2. Р. 14–19.
22. Bauman L., Barth R.J., Rosenkranz K.M. Breast conservation in women with multifocal-multicentric breast cancer: is it feasible? // Ann. Surg. Oncol. 2010. Suppl. 3. Р. 325–329. doi: 10.1245/s10434-0101247-1.
23. Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. Vol. 84 (1). P. 84–101.
24. Ceilley E., Jagsi R., Goldberg S., Grignon L., Kachnic L., Powell S., Taghian A. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61. (2). P. 365–367.
25. Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.
26. Childs S.K., Chen Y.H., Duggan M.M., Golshan M., Pochebit S., Wong J.S., Bellon J.R. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 84 (5). Р. 1133–1138. doi: 10.1016/j.ijrobp.2012.02.048.
27. Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.
28. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., Godwin J., Gray R., Hicks C., James S., MacKinnon E., McGale P., McHugh T., Peto R., Taylor C., Wang Y. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials // Lancet. 2005. Vol. 366 (9503). Р. 2087–2106.
29. Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83
30. Dragun A.E., Huang B., Gupta S., Crew J.B., Tucker T.C. One Decade Later: Trends and Disparities in the Application of Post-Mastectomy Radiotherapy Since the Release of the American Society of Clinical Oncology Clinical Practice Guidelines // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (5). e. 591–596. doi: 10.1016/j.ijrobp.2012.02.002.
31. Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.
32. Duraker N., Demi D., Bati B., Yilmaz B.D., Bati Y., Çaynak Z.C., Sobutay E. Survival Benefit of Post-mastectomy Radiotherapy in Breast Carcinoma Patients with T1-2 Tumor and 1–3 Axillary Lymph Node(s) Metastasis // Jpn. J. Clin. Oncol. 2012. Vol. 42 (7). Р. 601–608. doi: 10.1093/jjco/hys052.
33. Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.
34. Floyd S.R., Taghian A.G. Post-mastectomy radiation in large nodenegative breast tumors: does size really matter? // Radiother Oncol. 2009. Vol. 91 (1). Р. 33–37. doi: 10.1016/j.radonc.2008.09.015.
35. Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.
36. Fodor J., Polgar C., Major T., Németh G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size // Strahlenther Onkol. 2003. Vol. 179 (3). Р. 197–202.
37. Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.
38. Fortin A., Dagnault A., Blondeau L., Vu T.T., Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breastconserving surgery with or without regional irradiation // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65 (1). Р. 33–39.
39. Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.
40. Garg A.K., Strom E.A., McNeese M.D., Buzdar A.U., Hortobagyi G.N., Kuerer H.M., Perkins G.H., Singletary S.E., Hunt K.K., Sahin A., Schechter N., Valero V., Tucker S.L., Buchholz T.A. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2004. 59 (1). P. 138–145.
41. Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.
42. Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J. Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer // Ann. Oncol. 2009. Vol. 20. Р. 1319–1329. doi: 10.1093/annonc/mdp322.
43. Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.
44. Hamamoto Y., Ohsumi Sh., Aogi K., Shinohara S., Nakajima N., Kataoka M., Takashima S. Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy // Breast Cancer. 2013. Vol. 20 (3). Р. 247–253. doi: 10.1007/s12282-012-0335-4.
45. Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.
46. Hastings J., Iganej S., Huang C., Huang R., Slezak J. Risk Factors for Locoregional Recurrence After Mastectomy in Stage T1N0 Breast Cancer // Am. J. Clin. Oncol. 2014. Vol. 37 (5). P. 486–491. doi: 10.1097/COC.0b013e31827e54c2.
47. Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.
48. Jagsi R., Raad R.A., Goldberg S., Sullivan T., Michaelson J., Powell S.N., Taghian A.G. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62 (4). P. 1035–1039.
49. Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.
50. Kubicky C., Mongoue-Tchokote S. Prognostic Significance of the Number of Positive Lymph Nodes in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2, and 3 Positive Lymph Nodes Be Grouped Together? // Int. J. Radiat. Oncol. Biol. Phys. 2013. Vol. 85 (5). P. 1200–1205. doi: 10.1016/j.ijrobp.2012.11.005.
51. Kunkler I.H., Canney P., van Tienhoven G., Russell N.S. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: The MRC/EORTC SUPREMO trial // Clin. Oncol. (R. Coll. Radiol.). 2008. Vol. 20 (1). Р. 31–34.
52. Kyndi M., Srensen F.B., Knudsen H., Overgaard M., Nielsen H.M., Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group // J. Clin. Oncol. 2008. Vol. 26 (9). Р. 1419–1426. doi: 10.1200/JCO.2007.14.5565.
53. Lee J.C., Truong P.T., Kader H.A., Speers C.H., Olivotto I.A. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer // Clin. Oncol. 2005. Vol. 17. (8). P. 623–629.
54. Livi L., Meattini I., Di Cataldo V., Cardillo Cde L., Scotti V., Sanchez L., Nori J., Agresti B., Iermano C., Pasquetti E.M., Bianchi S., Cataliotti L., Biti G. Postmastectomy radiotherapy in breast cancer adjuvant treatment // Minerva Chir. 2010. Vol. 65 (5). P. 527–536.
55. Martinez-Ramos D., Escrig J., Torrella A., Hoashi J.S., Alcalde M., Salvador J.L. Risk of recurrence of non-metastatic breast cancer in women under 40 years: a population registry cancer study in a European country // Breast J. 2012. Vol. 18. (2). Р. 118–123. doi: 10.1111/j.15244741.2011.01208.x.
56. Matsunuma R., Oguchi M., Fujikane T., Matsuura M., Sakai T., Kimura K., Morizono H., Iijima K., Izumori A., Miyagi Y., Nishimura S., Makita M., Gomi N., Horii R., Akiyama F., Iwase T. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (3). Р. 845–852. doi: 10.1016/j.ijrobp.2011.08.029.
57. Miles R.C., Gullerud R.E., Lohse C.M., Jakub J.W., Degnim A.C., Boughey J.C. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age // Ann. Surg. Oncol. 2012. Vol. 19 (4). Р. 1153–1159. doi: 10.1245/s10434-011-2084-6.
58. Moo T. A., McMillan R., Lее M., Stempel M., Patil S., Ho A., ElTamer M. Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph Nodes // Ann. Surg. Oncol. 2013. Vol. 20 (10). Р. 3169–3174. doi: 10.1245/s10434-013-3117-0.
59. Munshi A., Prabhu A., Kunkler I. Post mastectomy radiotherapy in one to three lymph node positive breast cancer // Acta Oncol. 2012. Vol. 51 (4). Р. 547–550. doi: 10.3109/0284186X.2011.633929.
60. Nagao Т., Kinoshita Т., Tamura N., Hojo T., Morota M., Kagami Y. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2013. Vol. 18 (1). Р. 54–61. doi: 10.1007/s10147-0110343-y.
61. Nixon A., Neuberg D., Hayes D., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. Vol. 12. Р. 888–894.
62. Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. Vol. 82 (3). P. 247−253.
63. Panoff J.E., Hurley J., Takita C., Reis I.M., Zhao W., Sujoy V., Gomez C.R., Jorda M., Koniaris L., Wright J.L. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation // Breast Cancer Res. Treat. 2011. Vol. 128 (3). Р. 899–906. doi: 10.1007/s10549-011-1495-1.
64. Patani N., Carpenter R. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer // Breast J. 2010. Vol. 16 (3). Р. 222–232. doi: 10.1111/j.1524-4741.2010.00917.x.
65. Paul S., Srivastava K., Chaudhuri T., Rathor S. Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate? // Clin. Cancer Investig J. 2013. Vol. 2. Р. 14–19.
66. Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. Vol. 84 (1). P. 84–101.
67. Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.
68. Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.
69. Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83
70. Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.
71. Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.
72. Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.
73. Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.
74. Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.
75. Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.
76. Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.
77. Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.
78. Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.
79. Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.
Review
For citations:
Simonov K.A., Startseva Zh.A., Slonimskaya E.M. RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS. Siberian journal of oncology. 2015;1(1):76-83. (In Russ.)
Views:
1928
Email this article 
